AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Biohaven's 15min Chart Triggers MACD Death Cross, Bollinger Bands Narrowing
ByAinvest
Monday, Jun 23, 2025 10:32 am ET1min read
According to the 15-minute chart of Biohaven, the MACD indicator has crossed below the signal line, signaling a potential decline in the stock price. Additionally, the Bollinger Bands are narrowing, indicating a decrease in the magnitude of stock price fluctuations. This suggests that the stock price may continue to fall, with a lower likelihood of sudden or drastic price movements.
June 19, 2025 - Biohaven Pharmaceuticals Inc. (BHVN) has seen a significant adjustment in its price target by JP Morgan analyst Tessa Romero. The new target price has been lowered from $68.00 to $55.00, representing a 19.12% decrease [1]. Despite this reduction, Romero maintains an "Overweight" rating, indicating potential upside for the stock.The adjustment is primarily due to recent developments in Biohaven's pipeline. The U.S. launch of troriluzole for spinocerebellar ataxia has been delayed to the fourth quarter, and potential revenue from BHV-2100 for acute migraine has been excluded following a failed Phase 2 proof-of-concept trial [2].
Analysts remain optimistic about Biohaven's prospects. The average one-year price target from 13 analysts is $54.46, with a high estimate of $75.00 and a low estimate of $21.00, implying an average upside of 274.05% from the current price of $14.56 [1][2]. Additionally, 16 brokerage firms have an average recommendation of 1.6, indicating an "Outperform" status [1][2].
Technical indicators also suggest a potential downward trend. The 15-minute chart of Biohaven shows that the MACD indicator has crossed below the signal line, signaling a potential decline in stock price. The narrowing of the Bollinger Bands indicates a decrease in the magnitude of stock price fluctuations, further suggesting a lower likelihood of sudden or drastic price movements.
References:
[1] https://www.gurufocus.com/news/2933839/biohaven-bhvn-target-price-lowered-by-jp-morgan-analyst-bhvn-stock-news
[2] https://www.gurufocus.com/news/2933341/biohaven-bhvn-price-target-lowered-by-jpmorgan-to-55-bhvn-stock-news
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet